Research Comparison
Adipotide vs Semaglutide
A side-by-side research comparison of Adipotide and Semaglutide drawn from DRPSHP' peptide database records.
Adipotide
Adipotide, also catalogued as prohibitin-TP01, is a designed two-part molecule rather than something found in nature. One half is a homing sequence, CKGGRAKDC, a cyclic nine-residue peptide closed by a disulfide bond, which was picked out of phage-display libraries because it accumulates in the vasculature of white fat. The other half is D-(KLAKLAK)2, a synthetic amphipathic chain built from D-amino acids that has been used as a pro-apoptotic payload in other conjugates. Experiments were carried out in obese mice and then in rhesus monkeys, where changes in kidney tubule function were noted. Human data are very scarce, and most publications trace back to the group that engineered it.
Semaglutide
Semaglutide is best understood as human GLP-1 re-engineered so that it lasts. The native hormone is a 31-residue peptide destroyed in the bloodstream within a couple of minutes; semaglutide keeps the 31-residue frame but swaps in three changes, referenced to native numbering. Position 8 carries aminoisobutyric acid (Aib) so that dipeptidyl peptidase-4 cannot clip it, position 34 holds arginine instead of lysine, and the lysine at position 26 bears an 18-carbon diacid chain on a short spacer that lets the molecule ride on albumin. Receptor pharmacology, rodent models and a very extensive human trial record in metabolic disease all exist. A live question is how an albumin-bound molecule of this size reaches the brain regions where the receptor sits.
Reading a comparison
A comparison places two records side by side; it does not merge them. Each description above is drawn from that compound's own record, and the two were not necessarily characterised by the same methods, at the same time, or to the same level of detail. Before comparing any attribute, it is worth establishing that both records describe the substance you think they describe — names are not identifiers, and two entries sharing a name can differ in salt form, stereochemistry or the convention used to state a mass. Where a figure carries no method beside it, the comparison is between two reported numbers rather than between two measurements.